Robert de Jong, Ph.D.

Director Antibody Research & Technology at Genmab

Speaker

Dr. Rob N. de Jong has worked in different roles at the biotechnology company Genmab since 2007, related to molecular biology, CMC-supportive research, and protein engineering. Currently, Rob leads Genmab’s Antibody Format Development efforts, where his team marries rigorous science with playful protein engineering to address unsolved therapeutic challenges. His team applies biomolecular and structural insights to create novel therapeutic antibody platform technologies. Rob is an inventor of Genmab’s HexaBody® and HexElect® technologies.